Tyrogenex, Inc., a biotechnology company, engages in research and development of multi-kinase angiogenesis inhibitor for the treatment of solid tumors. The company has developed a novel, patented cancer therapeutic, X-82, a dual VEGFR/PDGFR inhibitor. The company was formerly known as Xcovery, Inc. The company was incorporated in 2006 and is based in West Palm Beach, Florida. The company operates as a subsidiary of Xcovery LLC.
Funding Rounds (3) - $19.3MUpdate
505 S. FLAGLER DRIVE
West Palm Beach, FL 33401